Able Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$466K Sell
408
-74
-15% -$87.3K 0.1% 87
2026
Q2
$569K Buy
482
+169
+54% +$173K 0.13% 76
2026
Q1
$255K Buy
313
+57
+22% +$57.8K 0.07% 105
2025
Q4
$236K Buy
+256
New +$245K 0.07% 100
2024
Q1
– Sell
-129
Closed -$75.5K – 360
2023
Q4
$75.5K Buy
+129
New +$75.3K 0.07% 110

Other funds holding LLY

Able Wealth Management's LLY Position: Q3 2026 in Review

Able Wealth Management reduced its Eli Lilly (LLY) stake by 15% in Q3 2026, selling an estimated $87.3K and leaving 408 shares worth $466K. The position accounts for 0.1% of the portfolio, ranked #87.

Able Wealth Management first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. The position peaked at $569K in Q2 2026. 1,645 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Able Wealth Management held 408 shares of Eli Lilly worth $466K as of Q3 2026.
  • Able Wealth Management sold 74 Eli Lilly shares in Q3 2026, an estimated $87.3K.
  • Eli Lilly made up 0.1% of Able Wealth Management's portfolio in Q3 2026, its #87 holding.
  • Able Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • Able Wealth Management's Eli Lilly position peaked at $569K in Q2 2026.
  • 1,645 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Able Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.